Related Experiment Video
Updated: May 16, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Phytochemicals as promising agents in Axl-targeted cancer treatment
1Department of Biochemistry and Molecular Biology, School of Medicine, Yeungnam University, Daegu 42415, Korea.
Abstract:
Axl, a receptor tyrosine kinase, plays a critical role in various cellular processes, such as survival, proliferation, migration, and immune response regulation. Dysregulation of Axl, particularly its overexpression and activation, is implicated in several cancers, where it has been found to facilitate tumor growth, metastasis, and the development of resistance to chemotherapy. Consequently, the inhibition of Axl has garnered significant interest as a potential strategy for cancer treatment. Natural compounds, known for their structural diversity and inherent bioactivity, are a valuable resource for drug discovery. These compounds offer a vast array of chemical structures that can serve as potential inhibitors of Axl, thereby providing novel approaches to modulate its activity. Researchers have identified various natural compounds that exhibit inhibitory effects on Axl, which underscore their potential for developing effective therapies. This review strives to provide a comprehensive overview of natural compounds that have been identified as Axl inhibitors. It will examine the mechanisms through which these natural compounds exert their inhibitory effects on Axl and discuss their potential applications in therapeutic settings. By compiling and analyzing existing research, this review seeks to advance the understanding of natural compounds as viable candidates in the development of effective Axl-targeted therapies, ultimately contributing to improved outcomes in diseases marked by Axl dysregulation.
Insights
Natural compounds show promise in inhibiting Axl receptor tyrosine kinase (RTK), a key factor in cancer progression and drug resistance. This review explores these natural Axl inhibitors for potential cancer therapies.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Axl receptor tyrosine kinase (RTK) is crucial for cell survival, proliferation, migration, and immune response.
- Axl dysregulation, including overexpression, drives tumor growth, metastasis, and chemotherapy resistance in various cancers.
- Targeting Axl is a significant strategy for developing novel cancer treatments.
Purpose of the Study:
- To provide a comprehensive review of natural compounds identified as Axl inhibitors.
- To examine the mechanisms of action for these natural Axl inhibitors.
- To discuss the therapeutic potential of natural compounds in Axl-targeted cancer therapy.
Main Methods:
- Literature review of scientific databases for studies on natural compounds inhibiting Axl.
- Analysis of identified natural compounds for their chemical structures and bioactivity.
- Evaluation of reported mechanisms of Axl inhibition by these compounds.
Main Results:
- Various natural compounds have demonstrated inhibitory effects against Axl.
- These compounds exhibit diverse mechanisms for modulating Axl activity.
- The identified natural compounds represent a promising source for developing Axl-targeted cancer drugs.
Conclusions:
- Natural compounds offer a rich source of potential Axl inhibitors.
- Further research into these compounds could lead to effective Axl-targeted cancer therapies.
- Developing therapies based on natural Axl inhibitors may improve outcomes in Axl-dysregulated diseases.
More Related Videos
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drugs that Stabilize Microtubules
Treatment Resistant Cancers